Paid Clinical Trials Anchorage

Discover 22 paid clinical trials in Anchorage, Alaska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 22

Rilvegostomig & Fluoropyrimidine & Trastuzumab DeruxtecanA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Anchorage AK, Edmonton, Calgary, Walnut Creek CAshow 27 more

Code:

NCT06764875

Conditions

HER2-positive Gastric Cancer

Gastroesophageal Junction Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rilvegostomig

Trastuzumab deruxtecan

Trastuzumab

Pembrolizumab

5-fluorouracil

ZongertinibBeamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Anchorage AK, Vancouver, Beverly Hills CA, Los Angeles CAshow 15 more

Code:

NCT06581432

Conditions

Solid Tumours

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zongertinib

ZN-c3A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

Recruiting

PHASE2

Sponsor:

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Location:

Anchorage AK, Portland OR, Eugene OR, Reno NVshow 32 more

Code:

NCT04814108

Conditions

Uterine Serous Carcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ZN-c3

Metabolism-Informed CareMetabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

Recruiting

Sponsor:

Southcentral Foundation

Location:

Anchorage AK

Code:

NCT06556238

Conditions

Smoking Cessation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nicotine Metabolite Ratio

Molecular Residual DiseaseEXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Recruiting

Sponsor:

Exact Sciences Corporation

Location:

Anchorage AK, Vallejo CA, Palo Alto CA, Sioux Falls SDshow 30 more

Code:

NCT06401421

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ctDNA MRD test

Observational StudySchool Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska

Recruiting

Sponsor:

University of Arkansas

Location:

Anchorage AK

Code:

NCT05593484

Conditions

Hearing Loss

Eligibility Criteria

Sex: All

Age: 3 - 21

Healthy Volunteers: Accepted

Interventions

Standard Referral

Specialty Telemedicine Access for Referrals (STAR)

Golcadomide & RituximabA Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

Recruiting

PHASE2

Sponsor:

Celgene

Location:

Anchorage AK, Seattle WA, San Francisco CA, Salt Lake City UTshow 21 more

Code:

NCT06425302

Conditions

Lymphoma, Follicular

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Golcadomide

Rituximab

Cyclophosphamide

Doxorubicin

Vincristine

RAINBO BLUE & TAPERAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting

PHASE2

Sponsor:

Canadian Cancer Trials Group

Location:

Anchorage AK, Prince George, Vancouver, Victoriashow 32 more

Code:

NCT05640999

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vaginal brachytherapy

Adjuvant radiotherapy (EBRT +/- brachytherapy)

Observation

BCG & ALT-803A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

ImmunityBio, Inc.

Location:

Anchorage AK, Seattle WA, Sacramento CA, Sherman Oaks CAshow 20 more

Code:

NCT02138734

Conditions

Non-muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BCG+N-803( 50mg BCG/ Instillation+ N-803( 400 μg/instillation). )

BCG( 50mg/Instillation)

Disitamab Vedotin vs ChemotherapyDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Recruiting

PHASE3

Sponsor:

Seagen Inc.

Location:

Anchorage AK, Vancouver, Everett WA, Edmontonshow 34 more

Code:

NCT05911295

Conditions

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

disitamab vedotin

pembrolizumab

gemcitabine

cisplatin

carboplatin